Advertisement

Latest News

Rheumatoid Arthritis Burden Has Surged Over Last 30 Years

1 hour ago

Populations most affected by RA are also growing younger and broader since 1990.

Biologic Treatments Safe to Recommend for IgE-Mediated Food Allergy, Study Suggests

2 hours ago

New research has indicated increased food tolerance thresholds and desensitization from omalizumab and other biologics in comparison to placebo with no serious adverse effects.

Wearables Show Disrupted Sleep 3 Months Postpartum, With Teresa Lillis, PhD

2 hours ago

At SLEEP 2025, Lillis discussed how wearable data revealed disruptions in sleep consolidation up to 13 weeks postpartum despite total sleep duration nearing pre-pregnancy levels.

EVEREST: Dupilumab (Dupixent) Outperforms Omalizumab (Xolair) for CRSwNP, Asthma

3 hours ago

Phase 4 data highlight dupilumab’s superiority to omalizumab for all primary and secondary efficacy endpoints of CRSwNP, and in all asthma-related endpoints.

FDA Accepts Epinephrine (Anaphylm) Sublingual Film NDA for Type 1 Allergic Reactions

4 hours ago

With the FDA acceptance of the NDA, the agency has assigned a PDUFA target action date of January 31, 2026, and may require an Advisory Committee meeting for approval.

Advertisement
Advertisement